Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Tuberculosis vaccine 1 by Chengdu Keen Biotechnology for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer): Likelihood of Approval
Tuberculosis vaccine 1 is under clinical development by Chengdu Keen Biotechnology and currently in Phase III for Non Muscle Invasive...